Correlations Between MMPs and TIMPs Levels in Aqueous Humor from High Myopia and Cataract Patients

References

• McBrien NA, Lawlor P, Gentle A. Scleral remodeling during the development of and recovery from axial myopia in the tree shrew. Invest Ophthalmol Vis Sci 2000;41:3713–3719.
   PubMed Web of Science ®Google Scholar
• McBrien NA, Gentle A. Role of the sclera in the development and pathological complications of myopia. Prog Retin Eye Res 2003;22:307–338.
   PubMed Web of Science ®Google Scholar
• McBrien NA, Cornell LM, Gentle A. Structural and ultrastructural changes to the sclera in a mammalian model of high myopia. Invest Ophthalmol Vis Sci 2001;42:2179–2187.
   PubMed Web of Science ®Google Scholar
• Rada JA, Brenza HL. Increased latent gelatinase activity in the sclera of visually deprived chicks. Invest Ophthalmol Vis Sci 1995;36:1555–1565.
   PubMed Web of Science ®Google Scholar
• Rada JA, Perry CA, Slover ML, Achen VR. Gelatinase A and TIMP-2 expression in the fibrous sclera of myopic and recovering chick eyes. Invest Ophthalmol Vis Sci 1999;40:3091–3099.
   PubMed Web of Science ®Google Scholar
• Guggenheim JA, McBrien NA. Form-deprivation myopia induces activation of scleral matrix metalloproteinase-2 in tree shrew. Invest Ophthalmol Vis Sci 1996;37:1380–1395.
   PubMed Web of Science ®Google Scholar
• Siegwart JT Jr, Norton TT. Selective regulation of MMP and TIMP mRNA levels in tree shrew sclera during minus lens compensation and recovery. Invest Ophthalmol Vis Sci 2005;46:3484–3492.
   PubMed Web of Science ®Google Scholar
• Gao H, Frost MR, Siegwart JT Jr, Norton TT. Patterns of mRNA and protein expression during minus-lens compensation and recovery in tree shrew sclera. Mol Vis 2011;17:903–919.
   PubMed Web of Science ®Google Scholar
• Schippert R, Brand C, Schaeffel F, Feldkaemper MP. Changes in scleral MMP-2, TIMP-2 and TGFbeta-2 mRNA expression after imposed myopic and hyperopic defocus in chickens. Exp Eye Res 2006;82:710–719.
   PubMed Web of Science ®Google Scholar
• Guo L, Frost MR, He L, Siegwart JT Jr, Norton TT. Gene expression signatures in tree shrew sclera in response to three myopiagenic conditions. Invest Ophthalmol Vis Sci 2013;54:6806–6819.
   PubMed Web of Science ®Google Scholar
• Murphy G, Nagase H. Progress in matrix metalloproteinase research. Mol Aspects Med 2008;29:290–308.
   PubMed Web of Science ®Google Scholar
• Kahari V, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 1999;31:34–45.
   PubMed Web of Science ®Google Scholar
• Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim Biophys Acta 2000;1477:267–283.
   PubMed Web of Science ®Google Scholar
• Groblewska M, Siewko M, Mroczko B, Szmitkowski M. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer. Folia Histochem Cytobiol 2012;50:12–19.
   PubMed Web of Science ®Google Scholar
• Chirco R, Liu XW, Jung KK, Kim HR. Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev 2006;25:99–113.
   PubMed Web of Science ®Google Scholar
• Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161–174.
   PubMed Web of Science ®Google Scholar
• Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior Annu Rev Cell Dev Biol 2001;17:463–516.
   PubMed Web of Science ®Google Scholar
• Chavey C, Mari B, Monthouel MN, et al. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 2003;278:11888–11896.
   PubMed Web of Science ®Google Scholar
• Limaye AM, Desai KV, Chavalmane AK, Kondaiah P. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate. Mol Cell Endocrinol 2008;294:10–18.
   PubMed Web of Science ®Google Scholar
• Ma DH, Chen JK, Kim WS et al. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization. Ophthalmic Res 2001;33:353–362.
   PubMed Web of Science ®Google Scholar
• Webb KE, Henney AM, Anglin S, Humphries SE, McEwan JR. Expression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injury. Arterioscler Thromb Vasc Biol 1997;17:1837–1844.
   PubMed Web of Science ®Google Scholar
• Lakatos G, Hritz I, Varga MZ et al. The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases. Dig Dis 2012;30:289–295.
   PubMed Web of Science ®Google Scholar
• Gomez DE, De Lorenzo MS, Alonso DF, Andrade ZA. Expression of metalloproteinases (MMP-1, MMP-2, and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in schistosomal portal fibrosis. Am J Trop Med Hyg 1999;61:9–13.
   PubMed Web of Science ®Google Scholar
• Knittel T, Mehde M, Grundmann A, Saile B, Scharf JG, Ramadori G. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem Cell Biol 2000;113:443–453.
   PubMed Web of Science ®Google Scholar
• Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, Sogayar MC. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer 2009;9:20.
   PubMed Web of Science ®Google Scholar
• Gress TM, Müller-Pillasch F, Lerch MM, Friess H, Buchler M, Adler G. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer 1995;62:407–413.
   PubMed Web of Science ®Google Scholar
• Poruk KE, Firpo MA, Scaife CL et al. Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma. Pancreas 2013;42:193–197.
   PubMed Web of Science ®Google Scholar
• Gardner J, Ghorpade A. Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J Neurosci Res 2003;74:801–806.
   PubMed Web of Science ®Google Scholar
• Singh RD, Haridas N, Patel JB et al. Matrix metalloproteinases and their inhibitors: Correlation with invasion and metastasis in oral cancer. Indian J Clin Biochem 2010;25:250–259.
   PubMedGoogle Scholar
• Wallard MJ, Pennington CJ, Veerakumarasivam A et al. Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma. Br J Cancer 2006;94:569–577.
   PubMed Web of Science ®Google Scholar
• Kossakowska AE, Huchcroft SA, Urbanski SJ, Edwards DR. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin’s lymphomas in humans. Br J Cancer 1996;73:1401–1408.
   PubMed Web of Science ®Google Scholar
• Ma J, Wang J, Fan W et al. Upregulated TIMP-1 correlates with poor prognosis of laryngeal squamous cell carcinoma. Int J Clin Exp Pathol 2013;7:246–254.
   PubMed Web of Science ®Google Scholar
• Ylisirniö S, Höyhtyä M, Turpeenniemi-Hujanen T. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer–TIMP-1 as a prognostic marker. Anticancer Res 2000;20:1311–1316.
   PubMed Web of Science ®Google Scholar
• Moore CS, Crocker SJ. An alternate perspective on the roles of TIMPs and MMPs in pathology. Am J Pathol 2012;180:12–16.
   PubMed Web of Science ®Google Scholar
• Cui H, Seubert B, Stahl E et al. Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes. Oncogene 2015;34:3640–3650.
   PubMed Web of Science ®Google Scholar
• Jia Y, Hu DN, Zhu D et al. MMP-2, MMP-3, TIMP-1, TIMP-2, and TIMP-3 protein levels in human aqueous humor: Relationship with axial length. Invest Ophthalmol Vis Sci 2014;55:3922–3928.
   PubMed Web of Science ®Google Scholar